午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ShangHai Biochempartner Co.,Ltd

Firmenname:ShangHai Biochempartner Co.,Ltd
Telefon:177-54423994
E-Mail:2853530910@QQ.com
Nationalit?t:China
URL: www.biochempartner.com
Produkte insgesamt:7972
64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80

Produktkatalog

Vepalimomab195158-85-1
Fezakinumab1007106-86-6
Ensituximab1092658-06-4
Teprotumumab1036734-93-6
Mavrilimumab1085337-57-0
Morolimumab
Faralimomab167816-91-3
Enokizumab909875-08-7
Etrolizumab1044758-60-2
Atinumab1226761-65-4
Carlumab915404-94-3
Rontalizumab948570-30-7
Girentuximab916138-87-9
Suvizumab914257-21-9
Bectumomab158318-63-9
Minretumomab195189-17-4
Nerelimomab162774-06-3
Mogamulizumab1159266-37-1
Icrucumab1024603-92-6
Fulranumab902141-80-4
Rovelizumab339086-79-2
Enavatuzumab1062149-33-0
Dalotuzumab1005389-60-5
Itolizumab1116433-11-4
Glembatumumab1020264-78-1
Lebrikizumab953400-68-5
Intetumumab725735-28-4
Maslimomab127757-92-0
Altumomab156586-92-4
Sifalimumab1006877-41-3
Foralumab946415-64-1
Drozitumab912628-39-8
Samalizumab1073059-33-2
Ozoralizumab1167985-17-2
Pateclizumab1202526-59-7
Sirukumab1194585-53-9
Biotinyl Cystamine128915-82-2C14H26N4O2S3
AMG-131315224-26-1C21H12Cl4N2O3S
2,4-Dichlorophenoxyacetyl chloride(2,4-Dichlorphenoxy)acetylchlorid774-74-3C8H5Cl3O2
NCGC00378430920650-00-6C22H23N3O5S
Apostatin-12559703-06-7C19H27N3OS
NCC0072342583-66-6C22H28F3N7
AZ322288709-96-4C20H16N4O
Onartuzumab1133766-06-9
Ponezumab1178862-65-1
Quilizumab1228538-47-3
Patritumab1262787-83-6
Radretumab1253180-81-2
Tregalizumab1207446-68-1
Ublituximab1174014-05-1
Urelumab934823-49-1
Caplacizumab915810-67-2
Solitomab1005198-65-1
Flanvotumab1188277-05-5
Inclacumab1256258-86-2
Vatelizumab1238217-55-4
Tabalumab1143503-67-6
Ficlatuzumab1174900-84-5
Narnatumab1188275-92-4
Crenezumab1095207-05-8
Blosozumab1132758-87-2
Clazakizumab1236278-28-6
Fasinumab1190239-42-9
Enoticumab1192578-27-0
Duligotuzumab1314238-96-4
Demcizumab1243262-17-0
Vesencumab1205533-60-3
Indatuximab Ravtansine1238517-16-2
Dectrekumab1528523-94-5
Nemolizumab1476039-58-3
Lirilumab1000676-41-4
Tesidolumab1531594-08-7
Futuximab1310460-85-5
Imgatuzumab959963-46-3
Ligelizumab1322627-61-1
Bezlotoxumab1246264-45-8
Actoxumab1245634-25-6
Vandortuzumab Vedotin1471985-92-8
Evinacumab1446419-85-7
Lokivetmab1533403-95-0
Tafasitamab1422527-84-1
Isatuximab1461640-62-9
Lacutamab2187368-16-5
Andecaliximab1518996-49-0
SUC-ALA-ALA-PRO-PHE-PNA107409-54-1C30H34N6O8
Amivantamab2171511-58-1
Indusatumab Vedotin1514889-12-3
ML3392579689-83-9C26H32ClN3O5
Mc-Val-Ala-PAB-PNP1639939-40-4C32H37N5O10
YTX-4652225824-53-1C25H26N6O3
Bocidelpar2095128-20-2C25H27F3N2O3
SR16641338259-05-4C33H29N3O5
RY7851393748-80-5C21H20N4O2S
JYN423461903742-34-6C27H24BrN7O3
AZD-1940881413-29-2C20H29F2N3O2S
INE9632640567-43-5C19H26N6O2S
GI 181771305366-98-7C34H31N5O6
JQKD-822410512-38-6C27H40N4O5
(R)-GSK-36850322170140-50-6C22H24N6OS
SCD1 inhibitor-31282606-48-7C19H16FN7O2
64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Copyright 2019 ? ChemicalBook. All rights reserved